Form 4: IQVIA CEO Exercises SARs, Sells Shares

IQVIA Holdings Inc. CEO Ari Bousbib exercised stock appreciation rights and subsequently sold 77,592 shares of common stock on October 29, 2025.

Summary

• Ari Bousbib, Chairman, Chief Executive Officer & President of IQVIA Holdings Inc., reported transactions on October 29, 2025.
• Exercised 77,592 Stock Appreciation Rights (SARs) at an exercise price of $59.9 per share.
• Simultaneously sold 77,592 shares of common stock in multiple transactions.
• The sale prices ranged from $216.70 to $222.27 per share, with weighted average prices between $217.58 and $221.97.
• The total estimated proceeds from these sales are approximately $17.09 million.
• Following these transactions, Bousbib directly owns 807,163 shares of common stock and indirectly owns 543,302 shares through the Orohena Trust.
• Bousbib also holds 50,000 Stock Appreciation Rights after these transactions.

Sentiment

Score: 5

Explanation: This is a routine insider transaction (exercise of SARs and subsequent sale of shares) often pre-planned under a 10b5-1 plan, which typically has a neutral impact on sentiment.

Positives

• The exercise of Stock Appreciation Rights (SARs) indicates the underlying stock price has appreciated significantly from the SAR exercise price of $59.9 to the sale prices around $217-$222.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned, non-discretionary sale, which often mitigates negative investor perception of insider selling.

Negatives

• Insider selling, even when pre-planned, can sometimes be viewed by investors as a lack of confidence, although in this case, it is tied to an SAR exercise for liquidity or diversification purposes.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders might note the insider selling, but given it is an exercise-and-sell under a pre-planned 10b5-1 plan, the direct impact on investor sentiment is likely minimal.

Key Dates

Keywords

IQVIA Holdings Inc., IQV, Ari Bousbib, Form 4, Insider Trading, Stock Appreciation Rights, SARs, Common Stock, Share Sale, Executive Compensation, 10b5-1 Plan